Revolab is a remote blood testing and tracking platform. We are turning lab-grade blood test result data into health insights powered by AI. Vilnius-based HealthTech startup aiming to change the way people trail their medical care across Europe and beyond - without the need for users to leave their doorstep. What started as an ambitious idea to simplify the blood testing process a year ago, evolved into a startup with more that 100,000 € of revenues. We were a winner of the 2020 EIT Digital Venture Program and have closed a seed funding of 300,000 € in May 2021. We offer customers an at-home blood sample kit allowing for lab-grade results within 24 hours - reinforced with insights by general practitioners. Users collect a blood sample from their finger and ship it to our partner lab. Thereafter, they can access their data in their personal account and keep track of their results. Currently, there are more than 30 available health tests ranging from thyroid panels, STD tests to Covid-19 testing. Our blood collection kit is CE-certified as an in-vitro medical device and cleared for 27 EU markets and FDA-approved for the US. Furthermore, Revolab holds a medical license for Lithuania. As of now, our product is distributed mainly via our website and app. The current traction is solely in Lithuania, but we are close to launching in neighboring countries by the end of 2021. Furthermore, our service is reimbursed by Gjensidige and Compensa Group insurance partners. As a next step, we are reinforcing our technology stack by further improving algorithmic features, so the Revolab app will act as a trustworthy medical companion. We aim to strengthen our test interpretation tool with AI, so that end customers don’t only get results but also insights. Second, we aim to create a self-assessment tool based on user input to complement blood results and thereby provide better diagnostics by leveraging ML algorithms. Medical license nr. 4655 https://vaspvt.gov.lt